Zhang H, Cook D
Department of Surgery, University of Chicago, IL 60637.
Pharmacol Toxicol. 1994 Dec;75(6):327-36. doi: 10.1111/j.1600-0773.1994.tb00370.x.
One of the promising therapeutic uses of the potassium channel openers is in the management of cerebral vasospasm, a prolonged vasoconstriction of major cerebral arteries which follows aneurysmal subarachnoid haemorrhage. In this review, we first summarize the properties of potassium channels in cerebral vascular smooth muscle. Calcium-activated and ATP-dependent potassium channels are the major potassium channels identified in the cerebrovascular smooth muscle and both are believed to play a role in the regulation of cerebrovascular smooth muscle tone. The calcium-activated potassium channels can be activated by depolarization, by elevation of internal calcium and by some vasodilators. Some neuropeptides and potassium channel openers open the ATP-dependent potassium channels and produce vasodilation. We then review the effects of both synthetic and endogenous potassium channel openers in the cerebrovascular system, discuss their efficacy in the management of models of cerebrovascular spasm, and outline the clinical promise of these agents.
钾通道开放剂一个有前景的治疗用途是用于治疗脑血管痉挛,即动脉瘤性蛛网膜下腔出血后主要脑动脉的持续性血管收缩。在本综述中,我们首先总结脑血管平滑肌中钾通道的特性。钙激活钾通道和ATP依赖性钾通道是在脑血管平滑肌中鉴定出的主要钾通道,两者都被认为在调节脑血管平滑肌张力中起作用。钙激活钾通道可通过去极化、细胞内钙升高以及一些血管舒张剂激活。一些神经肽和钾通道开放剂可打开ATP依赖性钾通道并产生血管舒张作用。然后我们综述了合成和内源性钾通道开放剂在脑血管系统中的作用,讨论它们在治疗脑血管痉挛模型中的疗效,并概述这些药物的临床前景。